Literature DB >> 9568958

Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.

E M Salonen1, P W Parren, Y F Graus, A Lundkvist, P Fisicaro, O Vapalahti, H Kallio-Kokko, A Vaheri, D R Burton.   

Abstract

A panel of seven human monoclonal Fabs against Puumala virus (PUU) nucleocapsid protein (N) was obtained by panning an antibody phage-display library prepared from the spleen of a PUU-immune individual. Three antibodies reacted in immunoblotting and cross-reacted strongly with Tula and Sin Nombre virus recombinant N proteins. These antibodies mapped to the amino terminus of the N protein. One PUU glycoprotein 2 (G2)-specific Fab obtained against a novel epitope (G2c) cross-reacted with Khabarovsk virus but not with the other hantavirus serotypes. An N protein-specific Fab was successfully used as capture antibody to detect PUU-specific serum IgG and IgM antibodies in an enzyme immunoassay. The result demonstrates the usefulness of recombinant human Fabs as potential diagnostic tools.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568958     DOI: 10.1099/0022-1317-79-4-659

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Neutralizing human Fab fragments against measles virus recovered by phage display.

Authors:  Cristina de Carvalho Nicacio; R Anthony Williamson; Paul W H I Parren; Ake Lundkvist; Dennis R Burton; Ewa Björling
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Isolation and characterization of a hantavirus from Lemmus sibiricus: evidence for host switch during hantavirus evolution.

Authors:  O Vapalahti; A Lundkvist; V Fedorov; C J Conroy; S Hirvonen; A Plyusnina; K Nemirov; K Fredga; J A Cook; J Niemimaa; A Kaikusalo; H Henttonen; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 3.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

4.  Crystal Structure of Glycoprotein C from a Hantavirus in the Post-fusion Conformation.

Authors:  Shmuel Willensky; Hagit Bar-Rogovsky; Eduardo A Bignon; Nicole D Tischler; Yorgo Modis; Moshe Dessau
Journal:  PLoS Pathog       Date:  2016-10-26       Impact factor: 6.823

5.  The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.

Authors:  Aurelija Zvirbliene; Indre Kucinskaite-Kodze; Ausra Razanskiene; Rasa Petraityte-Burneikiene; Boris Klempa; Rainer G Ulrich; Alma Gedvilaite
Journal:  Viruses       Date:  2014-02-07       Impact factor: 5.048

Review 6.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.